Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
1 clinical trials · Condition
◉ Watch Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
| Record | Firm | Date |
|---|---|---|
| Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (NCT00665652) | Dartmouth-Hitchcock Medical Center | 2008-04-01 |
Track Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS) automatically
Every clearance here is in the API, with alerts when new ones post.